Breast Cancer Clinical Trials in San Antonio

Showing 361-380 of 492 trials

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

NCT00394082

The purpose of this study is to evaluate the safety and tolerability of weekly ABI-007 in combination with bevacizumab. The evaluation of progression-free survival of weekly ABI-007 in combination with bevacizumab for patients with previously untreated advanced/metastatic breast cancer.

Metastatic Breast Cancer

Celgene50 participantsStarted Jun 2006

Melbourne, Florida, United States • Ocoee, Florida, United States • Niles, Illinois, United States +17 more locations

WITHDRAWNPhase 4< 1 mile

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

NCT03988114

The reason for this study is to see if the drug abemaciclib in combination with nonsteroidal aromatase inhibitors (anastrozole or letrozole) is effective in participants with Hormone Receptor Positive (HR+), Human Epidermal Growth Factor Receptor 2 Negative (HER2-) advanced breast cancer that have certain disease characteristics.

Metastatic Breast Cancer

Eli Lilly and CompanyStarted Sep 2019

Daphne, Alabama, United States • Tempe, Arizona, United States • Fountain Valley, California, United States +116 more locations

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

Breast Cancer Trials in Other Cities

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer

MRI to Detect Breast Tumors in Women

Health Benefits of Expressive Writing: Study One

Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi

CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

AirXpanders AeroForm Tissue Expander System for Breast Reconstruction

Other Conditions in San Antonio